Related Experiment Videos
Antitumor effect of TNP-470 is not associated to decrease of angiogenesis in an experimental malignant
C Morales1, M Zurita, J Vaquero
1Neuroscience Research Unit of the Mapfre-Medicine Foundation, Puerta de Hierro Clinic, Autonomous University, Madrid, Spain.
Journal of Neuro-Oncology
|August 8, 2002
Summary
TNP-470 significantly inhibited neuroectodermic tumor growth in rats. However, this antitumor effect was not linked to its antiangiogenic properties, suggesting alternative mechanisms are at play.
Area of Science:
- Oncology
- Cancer Research
- Pharmacology
Background:
- Tumor growth is often linked to neovascularization.
- TNP-470, a synthetic analog of fumagillin, exhibits antiangiogenic and antitumor effects.
- Limited data exists on TNP-470's efficacy against cerebral tumors.
Purpose of the Study:
- To evaluate the antitumor effect of TNP-470 on malignant neuroectodermic tumors in rats.
- To assess the impact of TNP-470 on tumor vascularization.
Main Methods:
- An experimental model of malignant neuroectodermic tumor in Wistar rats was used.
- Rats received intratumoral injections of TNP-470 (30 mg/kg) three times weekly for four weeks.
- Tumor growth and vascular parameters (microvessel number, vascular area) were analyzed.
Main Results:
- TNP-470 treatment resulted in significant tumor growth inhibition compared to controls.
- No significant differences in microvessel count or total vascular area were observed between groups.
- Quantitative analysis of tumor vascular parameters did not show significant statistical differences.
Conclusions:
- TNP-470 demonstrates a significant antitumor effect on the studied neuroectodermic tumor.
- The antitumor activity of TNP-470 in this model is independent of its antiangiogenic capacity.
- Alternative antineoplastic mechanisms mediate TNP-470's efficacy against this tumor type.